Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0, 800, or 1600 mg/Day of S-2367 Administered Orally Once Daily With a Reduced Calorie Diet in Obese Males and Females

NCT00747929 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT00747929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00747929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0, 800, or 1600 mg/Day of S-2367 Administered Orally Once Daily With a Reduced Calorie Diet in Obese Males and Females
Lead sponsor
Shionogi
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
January 31, 2009
Enrollment
724 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

obesity